Dr. Xin Chen, Ph.D., Board Director
PhD - Investor & Member of the Board of Directors since T3's legal inception in 2013. Dr. Chen has a PhD in in Organic Chemistry. Currently, Xin Chen is the CEO of his own biotech startup and a professor at the Department of Pharmaceutical Engineering and Life Science, Changzhou University, China. He contributes to T3's science strategy and initiatives and is actively involved through his startup in the R&D for the synthetic compounds for medical use. He contributes to T3's science R&D strategy.